Authors state that the results are of great concern as it has implications for the long-term viability of azithromycin as part of dual therapy for the treatment of gonorrhoea.
A related commentary discusses this research. New antimicrobials are currently being assessed and further research should investigate alternative antimicrobial combinations, which will be essential to provide optimum therapy against this formidable pathogen, and probably other sexually transmitted infections also, such as M genitalium